Bryan Bickell diagnosed with multiple sclerosis
November 18, 2016
Photo-Bombing Cancer
November 21, 2016
Show all

Why this multiple sclerosis drug doesn’t work half the time 

The multiple sclerosis (MS) drug interferon-beta is reported to not work for up to half of patients.

Researchers say they’ve figured out why a multiple sclerosis drug simply doesn’t work for up to half of patients.

The drug, called interferon-beta, can prevent flare-ups, but has unpleasant side effects and is expensive.

A new study in mice points to biological mechanisms that can lead to a form of MS that doesn’t respond to the drug. Researchers were able to identify new drug candidates that might help MS patients when interferon-beta treatment fails.

“The study shows a really clear molecular mechanism that may explain why some people do not respond to interferon-beta treatment,” says Mari Shinohara, an associate professor of immunology at Duke University and a senior author of the study in Nature Neuroscience. “We’ve found what makes a difference in the response.”

Read Full Article: Why this multiple sclerosis drug doesn’t work half the time – Futurity

Read Full Article: Why this multiple sclerosis drug doesn’t work half the time – Futurity

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.